NeuroNotis (TM), a new offering for hospital customers designed to bring greater confidence to Zeto ONE's AI-enabled seizure detection. The NeuroNotis Report confirms AI-generated seizure burden ...

NeuroNotis™, a new offering for hospital customers designed to bring greater confidence to Zeto ONE's AI-enabled seizure ...

Leaders, clinicians and associates from Nemours Children’s Health were joined today by local residents, elected officials and healthcare advocates as they broke ground on Nemours Children’s Health, ...

Since 2017, the nonprofit Rebel Song Academy has been found to help adolescents deal with a variety of mental health ...

Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore synapses to improve the lives of patients worldwide, today announced the publication of ...

Spinogenix’s Fragile X Syndrome (FXS) drug is the first to show rescued well-established resting EEG abnormalities, ...

Discusses KCC2 Deep Dive and Pipeline Advances in CNS Disorders April 14, 2026 9:30 AM EDTCompany ParticipantsMeg Alexander ...

Intel, IBM and MythWorx are shrinking AI to run on 20 watts, the same power as the human brain. Inside the neuromorphic race ...

Alto Neurosciences is halting work on its schizophrenia prospect after the brain-penetrant drug flunked a phase 2 study. The Bay Area biotech evaluated 10 days of treatment with t ...

Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on precision medicines for neuropsychiatric disorders, today announced topline data from its Phase 2 ...

From birth to age two is a crucial time when the brain develop most rapidly, yet children in this age cohort are given ...

Eastern Education Group (EEG) has been named the winner of the Educational Trailblazer Award at the East Anglia Clean and ...